To reduce the occurrence of medication errors, a systemic approach was developed combining anti-neoplastic medication error reviews and morbidity and mortality conferences (M&MCs). We report the first experience of implementing this strategy in oncology.The case reports submitted to combined reviews were prepared by physicians and pharmacists, and medication error(s) were described and chronological and root-cause analyses were performed.Ten combined reviews were conducted, which involved the departments of haematology, medical oncology, pneumology, gastroenterology and clinical oncology pharmacy. A total of 91 errors were analysed, of which 3 had reached the patient. Thirty-four corrective actions were proposed; 53

作者：Florence, Ranchon；Beno?t, You；Gilles, Salles；Nicolas, Vantard；Vérane, Schwiertz；Chloé, Gourc；Noémie, Gauthier；Marie-Gabrielle, Guédat；Pierre-Jean, Souquet；Gilles, Freyer；Véronique, Trillet-Lenoir；Catherine, Rioufol

来源：Chemotherapy 2013 年 59卷 5期